Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Shares Repurchased (2018 - 2020)

Historic Shares Repurchased for Rocket Pharmaceuticals (RCKT) over the last 3 years, with Q1 2020 value amounting to $72000.0.

  • Rocket Pharmaceuticals' Shares Repurchased changed N/A to $72000.0 in Q1 2020 from the same period last year, while for Dec 2020 it was $72000.0, marking a year-over-year change of. This contributed to the annual value of $72000.0 for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q1 2020, Rocket Pharmaceuticals' Shares Repurchased is $72000.0.
  • Rocket Pharmaceuticals' Shares Repurchased's 5-year high stood at $727000.0 during Q2 2019, with a 5-year trough of -$727000.0 in Q4 2019.
  • Moreover, its 3-year median value for Shares Repurchased was $370000.0 (2018), whereas its average is $185000.0.
  • Within the past 5 years, the most significant YoY rise in Rocket Pharmaceuticals' Shares Repurchased was 20883.23% (2019), while the steepest drop was 20883.23% (2019).
  • Quarter analysis of 3 years shows Rocket Pharmaceuticals' Shares Repurchased stood at $668000.0 in 2018, then plummeted by 208.83% to -$727000.0 in 2019, then soared by 109.9% to $72000.0 in 2020.
  • Its Shares Repurchased stands at $72000.0 for Q1 2020, versus -$727000.0 for Q4 2019 and $727000.0 for Q2 2019.